Tag: Deviation

Case Study of an OOS Invalidated Without Justification During a Method Transfer In the competitive environment of pharmaceutical manufacturing, ensuring compliance with Good Manufacturing Practices (GMP) is crucial. One common…

CAPA Failure Exposed by Backdated Test Records in Stability Analysis In pharmaceutical manufacturing, maintaining data integrity is crucial for regulatory compliance and product quality. A recent incident involving backdated test…

Ignoring System Suitability Failures in Stability Analysis: A Case Study on Regulatory Risks In a recent audit of a pharmaceutical manufacturing facility, a concerning trend emerged concerning system suitability failures…

Examining Sample Preparation Errors During Regulatory Inspections In a recent FDA inspection at a pharmaceutical manufacturing facility, a critical sample preparation error was discovered, leading to significant regulatory implications. This…

Analysis of a Data Integrity Breach Caused by Backdated Test Records Pharmaceutical manufacturers face numerous challenges in maintaining compliance with GxP standards. A common issue is the integrity of data…

Case Study: Addressing Unapproved Chromatographic Integration in Routine Testing In the highly regulated pharmaceutical industry, deviations from standard operating procedures (SOPs) can lead to significant quality concerns and regulatory scrutiny.…

Addressing Analyst Training Gaps During Investigations: A Real-World Case Study In a recent GMP-compliant pharmaceutical facility, an analyst mishandled critical data during an investigation of a laboratory deviation. This scenario…

Analyzing Analyst Training Gaps Uncovered during FDA Inspections In the highly regulated pharmaceutical environment, ensuring compliance with Good Manufacturing Practices (GMP) is essential for maintaining product quality and integrity. A…

Exploring the Management of a System Suitability Failure Highlighted During FDA Inspection The pharmaceutical manufacturing environment requires strict adherence to Good Manufacturing Practice (GMP) guidelines, particularly within quality control laboratories.…

Addressing Unjustified OOS Invalidations: A Case Study on Regulatory Enforcement Risks In the highly regulated pharmaceutical industry, maintaining the integrity of data is critical for compliance and safety. A notable…

Addressing Unauthorized Method Modifications During FDA Inspections In a recent case study within a US-based pharmaceutical company, an unauthorized method modification was uncovered during a routine FDA inspection. This article…

Addressing a Gap in Analyst Training for Data Review in Pharmaceutical Quality Control In the world of pharmaceutical manufacturing and quality control, even minor lapses in training can lead to…